China SXT Pharmaceuticals Inc (SXTC) — Capital Reinvestment Ratio
China SXT Pharmaceuticals Inc (SXTC) has a Capital Reinvestment Ratio of 0.11x as of December 2022, meaning it reinvests 0% of its operating cash flow ($234.18K) in capital expenditures ($25.28K). See China SXT Pharmaceuticals Inc (SXTC) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China SXT Pharmaceuticals Inc Capital Reinvestment Ratio (2016–2022)
This chart tracks China SXT Pharmaceuticals Inc's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for China SXT Pharmaceuticals Inc (2016–2022)
Year-by-year Capital Reinvestment Ratio for China SXT Pharmaceuticals Inc from 2016 to 2022. For live market cap and broader valuation context, see China SXT Pharmaceuticals Inc (SXTC) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.23x | $268.29K | $62.49K | ▼ -46.5% |
| 2020 | 0.44x | $934.25K | $406.66K | ▼ -82.9% |
| 2019 | 2.55x | $239.19K | $610.09K | ▲ +366.1% |
| 2018 | 0.55x | $1.92 Million | $1.05 Million | ▼ -13.9% |
| 2017 | 0.64x | $293.04K | $186.31K | ▲ +19.6% |
| 2016 | 0.53x | $182.47K | $96.99K | — |